Author(s): Antonio Piga, Immacolata Tartaglione, Maria Rita Gamberini, Ersi Voskaridou, et al. Abstract: S844 Session topic: 28. Thalassemias Background: Serious hematologic conditions such as β-thalassemia are associated with an erythroid maturation defect leading to anemia and other clinical sequelae. Luspatercept (ACE-536) is being developed as an erythroid-maturation agent (EMA) for treatment of...
Pro zobrazení tohoto obsahu je třeba být přihlášen.